Close

Cabaletta Bio Inc. (CABA) PT Lowered to $17 at Chardan Capital Markets, Keeps 'Buy'

December 14, 2021 3:46 PM EST Send to a Friend
Chardan Capital Markets analyst Geulah Livshits lowered the price target on Cabaletta Bio Inc. (NASDAQ: CABA) to $17.00 (from $21.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login